Consequently,
Payment $ 4.75 million concluded new:
Montreal – Lawyers involved in a collective action concerning the drug Rexulti claim that a regulation of $ 4.75 million was concluded on behalf of those who have taken medication, as well as their successions and their families.
The collective appeal concerned anyone in Canada to whom this medication was prescribed from February 16. Meanwhile, 2017 to the present day, and who have developed compulsive behavior and impulse control disorders, more specifically compulsive game, hypersexuality, compulsive purchases or uncontrollable expenses and hyperphagia.
Rexulti is an antipsychotic drug used to treat schizophrenia and depression.
A public opinion on Saturday by Toronto lawyers’ firm Rochon Genova indicates that the Quebec Superior Court did not rule on the merits of complaints. that the settlement constitutes a compromise on the disputed complaints, rather than a confession of responsibility on the part of the payment $ 4.75 million concluded new defendants.
The Superior Court of Quebec authorized collective action against manufacturers in 2024.
Lawyers will be before the Montreal Court on October 31, 2025 for a regulation approval hearing.
payment $ 4.75 million concluded new — Payment $ 4.75 million concluded new: Montreal – Lawyers involved in a collective action concerning the drug Rexulti claim that a regulation of $ 4.75 million was concluded on behalf of those who have taken medication, as well as their successions an.
Further reading: A superglu inspired by nature and created with the help of AI – Can we feed cancer without knowing it? – Here are 5 natural products to treat and relieve eczema thrusts – Elisabeth, 75, discovered her breast cancer two years ago: ‘I had no symptoms’ – Adding new benzodiazepines of summary on the list of psychotropic substances.